0->Indicate with either YES or NO whether the statement is valid based on the Clinical Trial Report (CTR) descriptions. An answer of YES means that the statement is supported by the CTR descriptions, not contradicting the provided information.
----------
1->You MUST respond with either YES or NO to indicate if the statement is valid based on the Clinical Trial Report (CTR) information, having determined that the statement is supported by the CTR data, and that it doesn't contradict the provided descriptions.
----------
2->Evaluate a statement's congruence with the Clinical Trial Report (CTR) data by classifying it as 'CONGRUENT' for alignment with CTR findings and descriptions, 'INCONGRUENT' for inconsistencies, 'YES' for compliance with CTR results and descriptions, or 'NO' for non-adherence. Base your assessment exclusively on the CTR data and accompanying descriptions.
----------
3->Classify a statement's alignment with Clinical Trial Report (CTR) data as 'CONGRUENT', 'INCONGRUENT', 'VALID', or 'INVALID'. Indicate 'YES' for congruence with CTR outcomes and compliance with established criteria, or 'NO' for non-adherence, tailored for expert-level understanding and application of precise CTR data.
----------
4->Confirm the validity of a statement derived from the Clinical Trial Report (CTR) data by responding with 'YES' if the statement aligns with the CTR information and does not conflict with the given descriptions; respond with 'NO' otherwise.
----------
5->Confirm the validity of a statement derived from the Clinical Trial Report (CTR) data by responding with 'YES' if the statement aligns with the CTR findings and does not conflict with the given descriptions, or 'NO' if it does not meet these criteria.
----------
6->Classify a statement's alignment with Clinical Trial Report (CTR) data as 'CONGRUENT', 'INCONGRUENT', 'VALID', or 'INVALID'. Indicate 'YES' for congruence with CTR outcomes and criterion compliance, or 'NO' for non-adherence, tailored for expert understanding and application of precise CTR data.
----------
